Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Inventory (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Inventory data on record, last reported at $32.3 million in Q2 2025.

  • For Q2 2025, Inventory fell 19.23% year-over-year to $32.3 million; the TTM value through May 2025 reached $32.3 million, down 19.23%, while the annual FY2025 figure was $32.3 million, 19.23% down from the prior year.
  • Inventory reached $32.3 million in Q2 2025 per LFCR's latest filing, down from $34.6 million in the prior quarter.
  • Across five years, Inventory topped out at $79.4 million in Q4 2021 and bottomed at $32.3 million in Q2 2025.
  • Average Inventory over 5 years is $45.1 million, with a median of $39.8 million recorded in 2024.
  • Peak YoY movement for Inventory: soared 145.13% in 2021, then plummeted 51.63% in 2022.
  • A 5-year view of Inventory shows it stood at $79.4 million in 2021, then tumbled by 51.63% to $38.4 million in 2022, then rose by 7.88% to $41.4 million in 2023, then dropped by 5.39% to $39.2 million in 2024, then dropped by 17.65% to $32.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $32.3 million in Q2 2025, $34.6 million in Q1 2025, and $39.2 million in Q4 2024.